Related by context. All words. (Click for frequent words.) 67 siRNA therapeutic 67 targeting PCSK9 66 DiLA2 66 rxRNA 66 histone deacetylase HDAC 65 SNALP 65 PORxin TM 65 SNALP technology 65 systemic RNAi 65 Novavax VLP vaccine 65 Locked Nucleic Acid LNA 64 AtuRNAi 64 Onconase 64 Protectans 64 humanized monoclonal antibodies 64 Tekmira SNALP technology 64 ATL# [002] 64 theranostic 63 GeneICE 63 TOCOSOL 63 OncoVEX 63 LNP formulations 63 Nektar proprietary 63 Aganocide 63 butyrylcholinesterase 63 exon skipping 63 lipid nanoparticle 63 Zemiva TM 63 targeted radiotherapeutic 63 AN# novel 63 JAK inhibitors 63 Anticalins R 63 Tß4 63 Factor 5A 63 HCV protease inhibitors 63 mda 7 63 pharmacological chaperone 63 DermaVir 63 NTDDS 62 isoform selective 62 HyACT 62 Personalized Immunotherapy 62 epothilones 62 SinuNase ™ 62 recombinant subunit vaccine 62 Aganocide ® 62 antisense oligonucleotides 62 Anticalin ® 62 RNAi therapeutic targeting 62 therapeutic monoclonal antibody 62 ALN TTR# 62 TOCOSOL Camptothecin 62 Solazed TM 62 Maxy G# 62 Hedgehog inhibitor 62 THR beta agonist 62 lipid nanoparticles 62 NeoLipid R 62 AMPK activators 62 antimitotic 62 Octreotide 62 humanized antibodies 62 proprietary PEGylation 62 NEUGENE R 62 enzyme inhibitor 62 engineered RAP peptides 61 nanoviricides 61 acetonide FA 61 immunotoxins 61 NeoLipid TM 61 antagomirs 61 PSMA ADC 61 PEGylated 61 liposomal formulation 61 Cyclosert TM 61 transcutaneous immunization TCI 61 chimeric monoclonal antibody 61 Panzem 61 proteasome inhibitor 61 anionic backbone 61 antisense compounds 61 Posiphen TM 61 TransVax tm 61 adenovector 61 antiangiogenesis 61 MVA BN R 61 siRNA delivery 61 DCVax R 61 SinuNase TM 61 synthetic retinoid 61 CBLC# 61 Cyclosert 61 novel immunotherapeutic 61 short interfering RNA 61 RNAi therapeutic 61 chemically modified siRNA 61 Novosom 61 liposomal delivery 61 Calando proprietary 61 anticancer therapeutics 61 AAV vectors 61 polysaccharide polymer 61 Factor VIIa 61 GRNVAC1 61 Selective Electrochemical Tumor Ablation 61 JAK inhibitor 61 TELINTRA 61 plasmid DNA pDNA 61 candidate TNFerade biologic 61 Chimigen 60 TLR9 agonist 60 DsiRNA 60 Enkephalin 60 Anticalins ® 60 DPX Survivac 60 mTOR inhibition 60 rxRNA ™ compounds 60 antisense inhibitors 60 A3 adenosine receptor 60 cMET 60 Alfacell proprietary ribonuclease 60 Protexia R 60 AAV vector 60 AtuPLEX 60 Smac mimetics 60 MAGE A3 ASCI 60 DepoVax TM 60 HepDirect technology 60 novel RNAi therapeutics 60 G#DT 60 MAXY G# 60 RNA antagonists 60 volociximab 60 Anticalin R 60 anaplastic lymphoma kinase ALK 60 recombinant plasma 60 CINTREDEKIN BESUDOTOX 60 Novolimus 60 Ramoplanin 60 ZFP TF 60 adeno associated viruses 60 EndoTAG TM 60 MMP inhibitors 60 DiLA 2 60 HSP# inhibitor 60 siRNA compounds 60 proprietary DuraSite ® 60 NP2 Enkephalin 60 adenoviral 60 HTS assay 60 ZFP Therapeutics 60 novel peptide 60 small molecule activators 60 anti infective treatments 60 molecular chaperone 60 Vaxfectin TM 60 JAK#/JAK# 60 Morpholino 60 HepDirect 60 Sphingomab 60 Vascugel 60 carbohydrate polymer 60 homocysteine assay 60 Curaxin 60 mertansine 60 ALN PCS 60 HuCNS SC ® 60 Flt3 60 trastuzumab DM1 T DM1 60 staphylococcal vaccine 60 siRNAs targeting 60 Bioral 60 virus AAV 60 RONDEL TM 60 ENMD # 60 humanized monoclonal 60 NOD mouse 60 Prodarsan ® 60 siRNA therapeutics 60 ALN TTR 60 Potelligent Technology 60 adult mesenchymal stem 60 humanised monoclonal antibody 60 acetylcholinesterase AChE 60 vascular disrupting agents 60 sd rxRNA 60 cyclophilin inhibitors 60 siRNA binds 60 epithelial tumors 60 nalbuphine ER 60 HepDirect prodrug 60 Cand5 60 nucleotide analog 60 Spiegelmer ® 59 small molecule PEGylation 59 biologic therapeutics 59 Ataluren 59 Fleximer 59 immunotherapeutic approaches 59 CD# CEA 59 Vaxfectin adjuvant 59 PDE# inhibitors 59 oligodendrocyte progenitor cells 59 UsiRNAs 59 TTR gene 59 cannabinor 59 HDL Selective Delipidation 59 buccal delivery 59 DOS# 59 preclinically 59 M2 subunit 59 tumor specific antigen 59 cancer immunotherapies 59 Cathepsin S 59 synthetic analogues 59 diagnostic biomarker 59 immune modulating 59 Nektar pulmonary 59 alkylating agent 59 CMV vaccine 59 demonstrated antitumor activity 59 TriGrid ™ 59 LEAPS TM 59 Protexia 59 PROCHYMAL 59 telomerase inhibitor 59 Gleevec resistant 59 AAG geldanamycin analog 59 DNA plasmids 59 HSP# inhibitors 59 metaglidasen 59 delivered RNAi therapeutic 59 BrachySil TM 59 Vaxfectin 59 liposomal 59 kidney urologic 59 recombinant antibodies 59 ddRNAi 59 CYT# potent vascular disrupting 59 Symadex 59 benzimidazole 59 2DG 59 Squalamine 59 BioSilicon 59 vivo validation 59 P#X# antagonist 59 PNP inhibitor 59 anti CD# antibodies 59 anti infective therapeutics 59 MEK inhibitors 59 ocular formulation 59 VEGF inhibitors 59 PDE4 inhibitor 59 Phase IIb clinical trials 59 tumorigenicity 59 oncolytic virus 59 oncolytic 59 HQK 59 CCR1 59 protein tyrosine phosphatase 1B 59 KRAS oncogene 59 molecular chaperone regulation 59 Clusterin 59 bevacizumab Avastin ® 59 SMARTICLES ® 59 targeted antifolate 59 histone deacetylase inhibitor 59 oral salmon calcitonin 59 Surfaxin LS 59 Lisofylline LSF 59 HuMax TAC 59 novel immunomodulatory 59 ONCONASE R 59 Locked Nucleic Acid 59 Aviptadil 59 REG1 59 Atu# 59 stem cell pluripotency 59 immunotoxin 59 PORxin 59 PI3K/Akt pathway inhibitor 59 Davanat 59 DermaPrep 59 potently inhibit 59 NS#/#A protease 59 IMA# 59 short hairpin RNAs 59 ATL# [001] 59 targets Galectin receptors 59 Optimata 59 tubulin inhibitor 59 Interferon alpha 59 MEK inhibitor 58 ImmuneY2 58 MGd 58 BiTE 58 effector function 58 CORT # 58 carbohydrate compounds 58 immune modulatory 58 systemically administered 58 Chimigen TM 58 Angiocept 58 anticancer therapies 58 candidate deforolimus 58 ProMIS TM 58 TÎ ² 4 58 Vaxfectin R adjuvant 58 pan HDAC inhibitor 58 PrevOnco ™ 58 Xanafide 58 hematological indications 58 oral transdermal 58 Fludara ® 58 CEQ# 58 PCA3 gene 58 ORADUR 58 Bezielle 58 candidates Azedra TM 58 LentiVector 58 Exherin TM 58 FGFR 58 IMiDs ® 58 BRAF inhibitors 58 experimentally validated 58 AFFITOME R 58 selectively inhibit 58 HuLuc# 58 TIMERx 58 entinostat 58 Hedgehog antagonist 58 Occlusin TM 58 ZFN 58 OHR/AVR# 58 Bioral ® 58 rBChE 58 Psoraxine R 58 eTag assays 58 RhuDex ® 58 MVA BN 58 ALK inhibitors 58 platinum chemotherapeutic 58 HDL Therapy 58 protein kinase inhibitors 58 GW# [003] 58 IRX 2 58 antiproliferative effects 58 novel anticancer 58 inhibit angiogenesis 58 human pluripotent stem 58 TransVax ™ 58 oral picoplatin 58 Pertuzumab 58 immunoregulation 58 JAK2 inhibitor 58 TKM ApoB 58 HCV NS5B polymerase 58 Fc gamma receptors 58 PARP inhibition 58 selective modulator 58 busulfan 58 RNA interference RNAi therapeutics 58 adipose derived regenerative 58 PEG SN# 58 tiapamil 58 MAXY VII 58 HepaMate 58 oral prodrug 58 prescribed proton pump 58 OvaRex R 58 nonviral 58 Altastaph 58 zotarolimus 58 Bioral Amphotericin B. 58 triterpenoids 58 prostone 58 introduced NEUGENE 58 receptor tyrosine kinase inhibitor 58 TNF alpha antagonist 58 peptide conjugated 58 Cerashield 58 huC# DM4 58 synthetic lethality 58 genomic biomarker 58 advanced polymer conjugate 58 mediated inhibition 58 Isis antisense 58 Lpathomab 58 novel therapeutic antibodies 58 VitiGam 58 Panzem R NCD 58 SynCon TM DNA 58 Th2 cytokines 58 cathepsin K inhibitor 58 transgenic rats 58 KL4 Surfactant 58 parthenolide 58 JAK kinases 58 #ME# 58 Anavex #-# 58 Amplimexon 58 DiLA2 liposomes 58 Curaxins 58 inhibit EGFR 58 non nucleoside 58 cyclodextrin containing polymers 58 RNA antagonist 58 dasatinib Sprycel 58 Iluvien ® 58 investigational humanized monoclonal antibody 58 hyaluronidase enzyme 58 delipidation 58 Viprovex TM 58 preclinical efficacy 58 Preclinical studies suggest 58 Panzem R 58 IMiDs ® compound 58 humanized antibody 58 romazarit 58 Oligonucleotide 58 ZaBeCor 58 hESC derived cardiomyocytes 58 POTELLIGENT ® 58 INS# [001] 58 XL# inhibits 58 antitumoral 58 vinca alkaloid 58 Collategene 58 HepDirect R 58 small molecule tyrosine 58 potent cytotoxic 58 PRX# 58 antimetastatic 58 nanomedicines 58 IL# PE 58 SynCon 58 potent inhibition 58 proprietary intranasal insulin 58 midstage trials 58 NP2 58 Affinitak 58 RiVax 58 synDNA TM 58 ESPRIT therapy 58 rPA anthrax vaccine 58 CDDO Im 58 PDGF receptor 58 acyclovir Lauriad R 58 ASONEP 58 NEUGENE 58 indibulin 58 PEGPH# 58 immuno therapeutic 58 nucleoside analogs 58 Mucosal 58 ADME properties 58 LNPs 57 isoform selective inhibitors 57 myelofibrosis polycythemia vera 57 ZFP technology 57 Resten NG 57 Chemophase 57 rxRNA compounds 57 CRTH2 57 Biochronomer 57 MorphoSys proprietary 57 selectively inhibited 57 cysteamine bitartrate 57 mesenchymal stem cell 57 midstage clinical 57 glutamic acid decarboxylase 57 DNA methyltransferases 57 GSK# [002] 57 bone morphogenic protein 57 NV1FGF 57 HGS ETR1 mapatumumab 57 Tekmira lipid nanoparticle 57 ApoB SNALP 57 influenza VLP vaccine 57 histone deacetylase inhibitors 57 mitotic kinesin 57 personalized immunotherapy 57 ZFP 57 novel VDA molecule 57 MCSP respectively 57 sulfonylhydrazine class 57 Trofex 57 systemic RNAi therapeutic 57 SynCon ™ DNA 57 canagliflozin 57 GRNCM1 57 treat chronic sinusitis 57 molecular biomarkers 57 UltiMAb 57 p# inhibitor 57 kallikrein 57 human parthenogenetic stem 57 pharmacodynamic biomarkers 57 PKC# 57 Zalypsis 57 EP #R 57 OXIGON TM 57 intranasal insulin product 57 Adnectin 57 compound perifosine 57 NanoCrystal Technology 57 OvaRex ® MAb 57 TGR5 57 hormone LHRH antagonist 57 Curaxin CBLC# 57 PORxin TM platforms 57 thiazolides 57 NOD SCID mice 57 poly ADP ribose polymerase 57 mTOR inhibitors 57 Initiate Clinical Trial 57 cellular immunotherapy 57 MTP inhibitor 57 Epidermal Growth Factor Receptor 57 Lixivaptan 57 TLR9 agonists 57 LungExpress Dx 57 novel topoisomerase 57 Litx 57 ERK pathway 57 ISF# 57 NF kB Decoy 57 Xcytrin R 57 siRNA knockdown 57 riociguat 57 thalidomide Thalomid 57 GelSite polymer 57 reverse vaccinology 57 Nanobody ® 57 Systemic Delivery 57 bortezomib Velcade 57 Allovectin 7 57 neurotrophic 57 TM Aganocide 57 Temsirolimus 57 HER2 overexpression 57 PSN# [001] 57 inhibit metastasis 57 EGS# 57 microtubule inhibitor 57 ARIKACE ™ 57 oncolytic viruses 57 pharmacodynamic markers 57 IAP inhibitor 57 proteasome inhibitors 57 Sertoli cell 57 recombinant adeno associated 57 Radilex 57 flavopiridol 57 motesanib 57 poly ethylene glycol PEG 57 PEGylation technology 57 selective kinase inhibitors 57 Liprotamase 57 silico prediction 57 TriGrid 57 ASONEP ™ 57 next generation URAT1 57 ACTCellerate 57 anticoagulant reversing agent 57 Enzyme Replacement Therapy 57 LEUKINE 57 Phylomer ® 57 hESC derived 57 APC Targeting Technology 57 potent stimulator 57 SCIB1 57 K ras mutations 57 RNAi compounds 57 Wnt signaling pathway 57 miRNA therapeutics 57 fibrotic disease 57 XmAb# 57 monoclonal antibody mAb 57 Myolimus 57 selectively inhibiting 57 fibrin derived 57 BCR ABL inhibitors 57 Endotis 57 H#N# VLP vaccine 57 keratinocyte 57 HCV antiviral 57 anti CD3 monoclonal 57 using VIAdel TM 57 C. pneumoniae 57 histone deacetylase HDAC inhibitors 57 prophylactic vaccine 57 virotherapy 57 compound AEOL # 57 ANTISENILIN ® 57 therapeutic peptide 57 compound AEZS 57 Arcelis ™ 57 IL# PE#QQR 57 SEQureDx TM 57 Familial Adenomatous Polyposis FAP 57 Fc receptor 57 proprietary transdermal 57 AKT inhibitor 57 JAK3 57 telomerase inhibitor drug 57 MMP inhibitor 57 NPC 1C 57 siRNA sequences 57 Marqibo TM 57 therapeutic modality 57 delivers fluocinolone acetonide FA 57 anti angiogenic agent 57 amikacin 57 HepeX B 57 gastric retentive 57 immatics 57 IMiDs R 57 VEGF receptor inhibitor 57 selective inhibition 57 immunodeficiency disorders 57 Cardio Vascu Grow 57 ATPace TM 57 antibacterial therapeutics 57 Vicinium TM 57 Onalta ™ 57 TG# [003] 57 Myocet 57 potent inducer 57 Azedra ™ 57 nucleotide analogs 57 ZFP TFs 57 lentiviral 57 MolecularBreeding TM 57 multitargeted 57 rxRNA TM compounds 57 ghrelin antagonist 57 IAP inhibitors 57 QTinno TM 57 CCR2 57 recombinant enzyme 57 EC Cysteamine 57 Liposomal 57 GRN# 57 antifibrotic 57 synthetic peptides 57 replicon 57 Aurora Kinase 57 iPSC 57 patented Bioral 57 c myb 57 Omacetaxine 57 SuperAntibody 57 optimal dosing regimens 57 Chemokine 57 Medarex UltiMAb 57 mGluR2 NAM 57 drug zotarolimus 57 Deforolimus 57 BiovaxID TM 57 phage display technology 57 RECOTHROM R 57 BEMA TM Fentanyl 57 FTIs 57 matrix metalloproteases 57 OMP #R# 57 Soliris eculizumab 57 accumulate preferentially 57 Intravail ® 56 adipogenic 56 novel anti infective 56 Monoclonal antibody 56 selective estrogen receptor modulator 56 TBC# 56 CINtec R 56 endosomal release 56 malignant ascites 56 siRNA mediated 56 Pathway Inhibitor 56 redox active 56 GeoVax vaccine 56 oral JAK1 56 ESBA# 56 PF # [002] 56 cilengitide 56 PNT# 56 Captisol ® 56 Micromet proprietary BiTE 56 hES cells 56 CB2 selective 56 synthetic siRNAs 56 tafamidis 56 maturation inhibitors 56 mimetic compounds 56 triphendiol 56 allogeneic HSCT 56 molecular chaperone amplification 56 Tarvacin TM 56 PI3K inhibitor 56 MT#/MEDI-# 56 Affibody 56 anti angiogenic drugs 56 carbohydrate polymers 56 Olaparib 56 polymer conjugate technology 56 TOCOSOL Paclitaxel 56 immunotherapeutic vaccine 56 haplotyping 56 eligen R technology 56 alpha#beta# integrin 56 gefitinib Iressa 56 therapeutic monoclonal antibodies 56 metabonomics 56 neurotrophic factors 56 intranasal delivery 56 InterfeRx 56 nucleoside analogues 56 cationic lipids 56 PGL# 56 Xencor XmAb 56 RONDEL ™ 56 SAR# [004] 56 intranasal formulation 56 Fc fusion protein 56 cyclic peptide 56 Ozarelix 56 Cetrorelix 56 SERMs 56 morpholino 56 CA4P 56 MyVax ® 56 proprietary polysaccharide 56 Neogenix 56 Prednisporin 56 Aganocide TM 56 catalytic antioxidant compounds 56 OncoVex 56 GelSite R polymer 56 juvenile chondrocytes 56 Anticalin 56 somatostatin receptors 56 Archexin 56 BEZ# 56 OMP #M# 56 ALK inhibitor 56 RECOTHROM ® 56 intra abdominal infections 56 beta interferons 56 CRLX# 56 Leukine ® 56 vascular disrupting 56 DNAi 56 Nasulin ™ 56 PolyActive 56 RRM1 56 Lodamin 56 Plasmid DNA 56 anti CD3 56 GGF2 56 liposomal ciprofloxacin 56 tkRNAi 56 AAGP ™ 56 rhIGF-I/rhIGFBP-3 56 OTCBB HXBM developer 56 PLK1 SNALP 56 molecular diagnostic assay 56 Allovectin 7 r 56 topoisomerase II inhibitors 56 lipid particle 56 biotherapeutic drugs 56 DispersinB R 56 Dalbavancin 56 trans splicing 56 Dyax phage display 56 bispecific antibody 56 lentiviral vector 56 Insegia 56 TLE3 56 potent suppressor 56 EZN 56 ReN# 56 antiangiogenic drugs 56 C5aR 56 cytostatic 56 CoVal TM fusion 56 CTAP# Capsules 56 TPI ASM8 56 T#I [002] 56 interleukin IL -# 56 XmAb 56 TRAIL receptor antibodies 56 humanized anti 56 aurora kinase 56 siRNA molecules 56 HCV NS3 protease 56 Cytolin ® 56 elotuzumab 56 investigational monoclonal antibody 56 Bevasiranib 56 Biopump 56 lentiviral vectors 56 inhibiting tumor 56 Vascular Wrap TM 56 covering SNALP 56 integrative pharmacology 56 non porcine pancreatic 56 sirtuin inhibitors 56 DiLA2 Platform 56 metastatic neuroendocrine tumors 56 thymosin beta 4 56 Vidaza azacitidine 56 TAKSTA 56 nanoparticle aggregates 56 Enhanze 56 vosaroxin 56 HCV polymerase 56 HemoGenix 56 histone deacetylase HDAC inhibitor 56 Dr. Khvorova 56 Prodarsan R 56 NurOwn 56 small molecule defensin 56 Salmonella vector 56 albumin bound paclitaxel 56 adrenergic regulation 56 Dacogen decitabine 56 MOVIPREP R 56 Unit Dose Budesonide 56 telomerase therapeutic 56 deCODE chemistry 56 apoptotic pathway 56 HuCAL antibodies 56 FLT3 56 bioscavenger 56 Zybrestat 56 Ampligen ® 56 immunomodulatory properties 56 NovaBay Aganocide compounds 56 CXCR4 receptor 56 Phase 2a clinical trials 56 bone morphogenetic proteins BMPs 56 CXCR7 56 bladder ovarian 56 Afatinib 56 imatinib Gleevec 56 Neo Kidney Augment 56 SPRYCEL ® 56 selective adenosine 56 Nasdaq SGEN 56 thapsigargin 56 ulimorelin 56 ALV# 56 detection reagents 56 MGN# 56 insertional mutagenesis 56 lintuzumab SGN 56 peptidomimetic 56 cetuximab Erbitux ® 56 zinc finger nuclease 56 MediVas 56 molecularly targeted therapies 56 intradermal injection 56 NS4A 56 pharmacokinetic PK study 56 candidate XP# 56 Aplidin 56 anticancer compound 56 Targeted Chemotherapy 56 predictive biomarkers 56 generation NEUGENE antisense 56 OncoVEX GM CSF 56 AQUA ® 56 immunostimulatory 56 FK# 56 VeraTag 56 PPARγ 56 osteogenic 56 oncolytic virus therapies 56 proprietary MSCRAMM ® 56 ZFNs 56 JAK1 56 nonhuman primate model 56 PEGylated Fab fragment 56 BIM #A# 56 Pagoclone 56 cytotoxic therapies 56 DPOLT 56 radezolid 56 Corgentin 56 BioVant 56 peptides proteins 56 Tumor Necrosis Factor 56 endostatin 56 TKM PLK1 56 CompuFlo 56 HDL Mimetic Peptide 56 RhuDex R 56 fusion proteins 56 Fodosine 56 beta1 integrin 56 PTK# 56 vivo potency 56 glial derived neurotrophic 56 epigenetic therapies 56 chemotherapeutic drug 56 oral isotype selective HDAC 56 oral isoform selective HDAC 56 Presents Preclinical Data 56 patented NanoStat TM 56 E2F Decoy 56 nanoviricide drug 56 TAFA# 56 drug ISA# 56 Vascular Endothelial Growth 56 EVIZON ™ 56 topical formulations 56 aptamer therapeutics 56 EGFR pathway 56 trial evaluating PRX# 56 Anidulafungin 56 Chrysalin 56 RECALL VAX 56 molecularly targeted 56 lenalidomide dexamethasone 56 proprietary Biochronomer 56 M Enoxaparin 56 mTOR mammalian target 56 taxane resistant 56 FGFs 56 leading lipid nanoparticle 56 viral inactivation 56 γ secretase 56 ProteinChip 56 metabolomic profiling 56 Phase #b/#a clinical 56 ReCyte 56 Maribavir 56 Nanobodies ® 56 biosurgical 55 VA# [002] 55 antibody MAb 55 DNA methylation biomarkers 55 boron chemistry 55 EVIZON TM 55 melanocortin receptor agonists 55 cathepsins 55 Protein Kinase C 55 rifamycins 55 sd rxRNA compounds 55 GPR# agonist 55 OnDose TM 55 atacicept 55 Luteinizing Hormone Releasing Hormone 55 LEP ETU 55 vivo fluorescence imaging 55 Ophena 55 Pancreate 55 REP# 55 NS5A 55 factor PlGF 55 pan genotypic 55 NSCLC tumors 55 LentiVector technology 55 pafuramidine maleate 55 liposome formulation 55 XL# XL# 55 paclitaxel Taxol ® 55 CB2 receptor 55 Pruvel 55 IGF1R 55 vaccine GRNVAC1 55 novel oral anticoagulant 55 Myoblast Program 55 deforolimus 55 taxane derivative 55 NuMimetic TM 55 INTELLITAB TM 55 cytoprotective 55 Cytotoxic 55 Nanobody R 55 Neupogen ® 55 antiarrhythmic 55 EECP ® therapy 55 Thalomid ® 55 Pentraxin 2 55 lomitapide 55 Ecallantide 55 human IgG1 monoclonal 55 deacetylase inhibitors 55 DCVax R Prostate 55 DNA intercalator 55 cartilage regeneration 55 thymidylate synthase TS 55 proliferative disorders 55 CELLECTRA R 55 fosbretabulin 55 PI3K/mTOR 55 Oral NKTR 55 aerosolized KL4 surfactant